Christensen King & Associates Investment Services Inc. Takes Position in Oracle Corporation $ORCL

Key Points

• Christensen King & Associates Investment Services Inc. purchased a new stake in Oracle Corporation by acquiring 958 shares worth approximately $209,000 during the second quarter.
• Insiders have been actively selling shares, with Michael D. Sicilia selling 16,323 shares for over $5 million and Clayton M. Magouyrk selling 21,241 shares for about $6.3 million.
• Several analysts have upgraded their price targets for Oracle, with a consensus average target price of $303.44 reflecting a "Moderate Buy" rating from analysts.

Christensen King & Associates Investment Services Inc. bought a new stake in Oracle Corporation (NYSE:ORCL - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 958 shares of the enterprise software provider's stock, valued at approximately $209,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Redmont Wealth Advisors LLC purchased a new stake in Oracle during the first quarter worth about $27,000. Inlight Wealth Management LLC purchased a new stake in Oracle during the first quarter worth about $28,000. Iron Horse Wealth Management LLC boosted its holdings in Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock worth $29,000 after buying an additional 151 shares in the last quarter. Family Legacy Financial Solutions LLC purchased a new stake in Oracle during the second quarter worth about $60,000. Finally, Graybill Wealth Management LTD. purchased a new stake in Oracle during the first quarter worth about $39,000. Hedge funds and other institutional investors own 42.44% of the company's stock.

Insider Buying and Selling

In other news, insider Michael D. Sicilia sold 16,323 shares of the stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $313.60, for a total value of $5,118,892.80. Following the completion of the sale, the insider owned 110,094 shares of the company's stock, valued at $34,525,478.40. This represents a 12.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of the stock in a transaction on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the sale, the insider directly owned 78,000 shares of the company's stock, valued at $23,174,580. The trade was a 21.40% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 78,247 shares of company stock valued at $22,090,505. 42.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Stifel Nicolaus boosted their price objective on shares of Oracle from $250.00 to $350.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. Scotiabank restated an "outperform" rating on shares of Oracle in a research report on Wednesday, September 10th. Mizuho lifted their target price on shares of Oracle from $300.00 to $350.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 10th. Loop Capital set a $135.00 target price on shares of Oracle in a research report on Tuesday, June 10th. Finally, Cowen restated a "buy" rating and set a $375.00 target price on shares of Oracle in a research report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $303.44.

Oracle Stock Performance

Shares of ORCL stock opened at $329.10 on Tuesday. Oracle Corporation has a one year low of $118.86 and a one year high of $345.72. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The company has a 50 day moving average price of $253.63 and a 200 day moving average price of $196.92. The firm has a market capitalization of $935.21 billion, a price-to-earnings ratio of 76.18, a price-to-earnings-growth ratio of 3.34 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. During the same period last year, the company posted $1.39 EPS. The business's revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Sell-side analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a $0.50 dividend. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.6%. Oracle's dividend payout ratio is presently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.